Studying the role of probiotics for the treatment of early stage of cervical cancer in Bangladesh
- Conditions
- Health Condition 1: N870- Mild cervical dysplasia
- Registration Number
- CTRI/2021/07/034616
- Lead Sponsor
- BANBEIS Ministry of Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Applicable
- Sex
- Not specified
- Target Recruitment
- 0
Female
Age: 18 -45 years
Non-pregnant
Willing to take conservative treatment and colposcopy (if required)
Not taking antibiotics, probiotics, vitamins and other medications for any other co morbidity within one month before participating in this research work.
Women irrespective of their ethnicity, parity, phase in their cycle and use of contraception, Smoking, alcohol consumption habits.
Women with a diagnosis of LSIL on their latest PAP smear
Women with a first as well as with a repeat LSIL diagnosis
Age: female below 18 years and above 45 years
Pregnant
Not willing to take conservative treatment and colposcopy (if required)
Taking antibiotics, probiotics, vitamins and other medications for any other co morbidity within one month before participating in this research work.
Women with a previous history of cervical treatment
Women with HIV or hepatitis B/C positive with autoimmune diseases
Patients suffering from invasive cervical cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method absence or decrease the severity of clinical signs-symptoms.Timepoint: Day 0, day 180
- Secondary Outcome Measures
Name Time Method The change in vaginal microbiotia (composition, abundance and diversity). <br/ ><br>Lactobacillus level of all groups <br/ ><br>Detection of HPV of patients <br/ ><br>adverse eventsTimepoint: Day 0 and Day 180